Kirkham BW, Corkill MM, Davison SC, Panayi GS. Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses. J Rheumatol
1991;18:821–5.
Radner H, Smolen JS, Aletaha D. Remission in rheumatoid arthritis: benefit over low disease activity in patient reported outcomes and costs. Arthritis Res Ther 2014; 16: R56.
Bernard Combe, Robert Landewe, Claire I Daien, Charlotte Hua, Daniel Aletaha, Jose María Álvaro-Gracia. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 2017;76:948–959. doi:10.1136/annrheumdis-2016-210602
Smolen, J.S. et. al. 2016 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann Rheum Dis 76(6):960-977
Schipper, L.G.; van Hulst, L.T.; Grol, R.; van Riel, P.L.; Hulscher, M.E.; Fransen, J. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome Rheumatology 2010, 49(11):2154-64 doi: 10.1093/rheumatology/keq195. Epub 2010 Jul 29.
Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations
for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086–93.
